[1]曹毛毛,陈万青.GLOBOCAN 2020全球癌症统计数据解读［J］.中国医学前沿杂志,2021,13(3):63-69.
CAO MM,CHEN WQ.Interpretation on the global cancer statistics of GLOBOCAN 2020［J］.Chinese Journal of the Frontiers of Medical Science,2021,13(3):63-69.
[2]ZHENG R,ZHENG S,ZENG H,et al.Cancer incidence and mortality in China,2016［J］.Journal of the National Cancer Center,2022,2(1):1-9.
[3]XIA C,DONG X,LI H,et al.Cancer statistics in China and United States,2022:profiles,trends,and determinants［J］.Chin Med J (Engl),2022,135(5):584-590.
[4]MOHANAN P,SUBRAMANIYAM S,MATHIYALAGAN R,et al.Molecular signaling of ginsenosides Rb1,Rg1,and Rg3 and their mode of actions［J］.J Ginseng Res,2018,42(2):123-132.
[5]WANG S,LONG S,WU W.Application of traditional Chinese medicines as personalized therapy in human cancers［J］.Am J Chin Med,2018,46(5):953-970.
[6]WANG Z,QI F,CUI Y,et al.An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics［J］.Biosci Trends,2018,12(3):220-239.
[7]HUANG Y,ZHU J,LIN X,et al.Potential of fatty oils from traditional Chinese medicine in cancer therapy:a review for phytochemical,pharmacological and clinical studies［J］.Am J Chin Med,2019,47(4):727-750.
[8]CHEN X,CHEN X,GAO J,et al.Astragaloside III enhances anti-tumor response of NK cells by elevating NKG2D and IFN-γ［J］.Front Pharmacol,2019,10:898.
[9]LI K,LI S,WANG D,et al.Extraction,characterization,antitumor and immunological activities of hemicellulose polysaccharide from astragalus radix herb residue［J］.Molecules,2019,24(20):3644.
[10]WU TH,YEH KY,WANG CH,et al.The combination of astragalus membranaceus and angelica sinensis inhibits lung cancer and cachexia through its immunomodulatory function［J］.J Oncol,2019,2019:9206951.
[11]SUN R,XIANG J,ZHOU Q,et al.The tumor EPR effect for cancer drug delivery:current status,limitations,and alternatives［J］.Adv Drug Deliv Rev,2022,191:114614.
[12] 董磊，魏茜茜，李孟壕，等.超声联合藤黄酸纳米粒抗人神经胶质瘤的研究［J］.现代肿瘤医学，2023,31（5）:789-794.
DONG L,WEI QQ,LI MH,et al.Study on the effect of ultrasound combined with gambogic acid nanoparticles on human glioma［J］.Modern Oncology,2023,31(5):789-794.
[13]ZHANG D,ZHANG J,ZENG J,et al.Nano-gold loaded with resveratrol enhance the anti-hepatoma effect of resveratrol in vitro and in vivo［J］.Journal of Biomedical Nanotechnology,2019,15(2):288-300.
[14]SHARMA D,CHELVI TP,KAUR J,et al.Novel Taxol formulation:polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy［J］.Oncol Res,1996,8(7-8):281-286.
[15]李琦，王炎，范忠泽，等.丹参酮ⅡA及其纳米粒诱导肝癌细胞凋亡及对p38 MAPK、TGFβ1信号蛋白表达的影响［J］.肿瘤，2008，28(1):8-12.
LI Q,WANG Y,FAN ZZ,et al.Effects of tanshinone II A and its nanoparticles on apoptosis and expression of p38 MAPK and TGFβ1 signaling proteins of hepatoma cells in mice［J］.Tumor,2008,28(1):8-12.
[16] 褚丽萍，刘金剑，杨翠红，等.阿霉素前药纳米粒/姜黄素联合递送系统的构建及其抗肿瘤研究［J］.中国生化药物杂志，2016,36(1):12-15,19.
CHU LP,LIU JJ,YANG CH,et al.Construction of a co-delivery system based on doxorubicin prodrug nanoparticle and curcumin and its application in anti-tumor study［J］.Chinese Journal of Biochemical Drugs,2016,36(1):12-15,19.
[17]LIU Q,LI J,PU G,et al.Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy［J］.Drug Deliv,2016,23(4):1364-1368.
[18]杜文娟，王孝慈，周小红，等.探讨芦荟大黄素纳米脂质体联合5-氟尿嘧啶对人舌鳞癌CAL-27细胞增殖凋亡迁移的影响［J］.现代肿瘤医学，2023，31(9):1626-1632.
DU WJ,WANG XC,ZHOU XH,et al.The effect of aloe-emodin nanoliposomes combined with 5-fluorouracil on proliferation,apoptosis,invasion and migration of human tongue squamous cell carcinoma CAL-27 cells［J］.Modern Oncology,2023,31(9):1626-1632.
[19]龚明涛，张钧寿，沈益.羟基喜树碱纳米乳的制备及其抗癌作用初步研究［J］.中国天然药物，2005，3(1):41-43.
GONG MT,ZHANG JS,SHEN Y.Preparation of hydroxycamptothecin nanoemulsion and its anticancer effect［J］.Chinese Journal of Natural Medicines,2005,3(1):41-43.
[20] 孙春晓，王树森，李健斌，等.紫杉醇脂质体在晚期乳腺癌中应用的真实世界研究［J］.中华肿瘤杂志，2023,45(1):88-94.
SUN CX,WANG SS,LI JB,et al.A real-world study on the efficacy and safety analysis of paclitaxel liposomes in advanced breast cancer［J］.Chin J Oncol,2023,45(1):88-94.
[21] 刘晓亭,何凌,黄橙,等.贝伐珠单抗联合紫杉醇脂质体和卡铂治疗晚期卵巢癌患者的临床疗效及其对血清肿瘤标志物的影响［J］.临床合理用药杂志，2022，15(21):41-44.
LIU XT,HE L,HUANG C,et al.Clinical efficacy of bevacizumab combined with paclitaxel liposome and carboplatin in the treatment of advanced ovarian cancer patients and its influence on serum tumor markers［J］.Chinese Journal of Clinical Rational Drug Use,2022,15(21):41-44.
[22] 张日光,阳柳,陈绍俊,等.紫杉醇脂质体联合同步放化疗治疗宫颈癌疗效及安全性分析［J］.临床军医杂志，2022，50(3):283-285.
ZHANG RG,YANG L,CHEN SJ,et al.Efficacy and safety analysis of paclitaxel liposomes combined with concurrent chemoradiotherapy in the treatment of cervical cancer［J］.Clin J Med Offic,2022,50(3):283-285.
[23] 王青，杨觅.载紫杉醇重组高密度脂蛋白微球的制备和抗胃癌作用研究［J］.浙江医学,2020,42(2)：118-122,126.
WANG Q,YANG M.Preparation of paclitaxel loaded recombinant high density lipoprotein microspheres and its anti-gastric cancer effect［J］.Zhejiang Medical Journal,2020,42(2):118-122,126.
[24]STEFFES VM,ZHANG Z,MACDONALD S,et al.PEGylation of paclitaxel-loaded cationic liposomes drives steric stabilization of bicelles and vesicles thereby enhancing delivery and cytotoxicity to human cancer cells［J］.ACS Appl Mater Interfaces,2020,12(1):151-162.
[25]陈静,张晓云,倪京满.鬼臼毒素纳米脂质体对人白血病多药耐药细胞的凋亡诱导和耐药逆转作用［J］.兰州大学学报,2008,24(1):1-4.
CHEN J,ZHANG XY,NI JM.Reversion of drug-resistance and induction of apoptosis by podophyllotoxin nanoliposome in human leukemia multidrug-resistant cells［J］.Journal of Lanzhou University,2008,24(1):1-4.
[26] 史毓杰,曾抗,李国锋,等.鬼臼毒素纳米脂质体对宫颈癌细胞增殖和凋亡的影响［J］.南方医科大学学报,2008,28(5):786-788.
SHI YJ,ZENG K,LI GF,et al.Effects of podophyllotoxin solid lipid nanoparticles on proliferation and apoptosis of cervical carcinoma cells［J］.Journal of Southern Medical University,2008,28(5):786-788.
[27]XI X,SUN J,XI D,et al.Realgar naoparticles inhibit migration,invasion and metastasis in a mouse model of breast cancer by suppressing matrix metalloproteinases and angiogenesis［J］.Curr Drug Deliv,2020,17(2):148-158.
[28]李秀荣,李慧杰,许艳艳.纳米雄黄抑制人乳腺癌MCF-7细胞上皮间质转化的机制探讨［J］.世界中医药,2016,11(3):495-497.
LI XR,LI HJ,XU YY.The mechanism of nanometer realgar to inhibit the epithelim mesenchymal transition of breast cancer MCF-7 cells［J］.World Chinese Medicine,2016,11(3):495-497.
[29]TIAN Y,WANG X,XI R,et al.Enhanced antitumor activity of realgar mediated by milling it to nanosize［J］.Int J Nanomedicine,2014,9:745-757.
[30]YU Y,ZHANG X,QIU L.The anti-tumor efficacy of curcumin when delivered by size/charge-changing multistage polymeric micelles based on amphiphilic poly(β-amino ester) derivates［J］.Biomaterials,2014,35(10):3467-3479.
[31]FANG L,CHEN B,LIU S,et al.Synergistic effect of a combination of nanoparticulate Fe3O4 and gambogic acid on phosphatidylinositol 3-kinase/Akt/Bad pathway of LOVO cells［J］.Int J Nanomedicine,2012,7:4109-4118.
[32] 徐炳欣,郑甲信,赵媛媛,等.葫芦素B固体脂质纳米粒对人神经母细胞瘤SK-N-SH细胞的体外细胞毒作用评价［J］.中国药学杂志,2012,47(23):1894-1898.
XU BX,ZHENG JX,ZHAO YY,et al.Cytotoxicity evaluation of cucurbitacin B solid lipid nanoparticles(SLN) on human neuroblastoma SK-N-SH cell line in vitro［J］.Chin Pharm J,2012,47(23):1894-1898.
[33]DUAN C,ZHANG D,WANG F,et al.Chitosan-g-poly(N-isopropylacrylamide) based nanogels for tumor extracellular targeting［J］.Int J Pharm,2011,409(1-2):252-259.
[34]ABDELMONEEM MA,ELNAGGAR MA,HAMMADY RS,et al.Dual-targeted lactoferrin shell-oily core nanocapsules for synergistic targeted/herbal therapy of hepatocellular carcinoma［J］.ACS Appl Mater Interfaces,2019,11(30):26731-26744.
[35]SUN D,ZOU Y,SONG L,et al.A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer［J］.Acta Pharmaceutica Sinica B,2022,12(1):378-393.
[36]王寒剑,韩栋梁,危文祥,等.叶酸修饰埃洛石纳米管负载姜黄素对乳腺癌细胞及移植瘤的放射增敏作用［J］.现代肿瘤医学,2023,31（13）：2379-2384.
WANG HJ,HAN DL,WEI WX,et al.Radiosensitization of breast cancer cells and transplanted tumors by folate modified halloysite nanotubes loaded with curcumin［J］.Modern Oncology,2023,31（13）：2379-2384.
[37]SONG XL,LIU S,JIANG Y,et al.Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG2000-transferrin in treatment of brain glioma［J］.European Journal of Pharmaceutical Sciences,2017,96:129-140.
[38]DESAI N,TRIEU V,DAMASCELLI B,et al.SPARC expression correlates with tumor response to albumin-bound paclitaxel in head and neck cancer patients［J］.Transl Oncol,2009,2(2):59-64.
[39]TANG H B,LI L,CHEN H,et al.Stability and in vivo evaluation of pullulan acetate as a drug nanoearrier［J］.Drug Delivery,2010,17(7):552-558.
[40]NA K,BUM LEE T,PARK KH,et al.Self-assembled nanopartieles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system［J］.Eur J Pharm Sci,2003,18(2):165-173.
[41]TEIJEIW-VALINO C,NOVOA-CARBALLAL R,BORRAJO E,et al.A multifunctional drug nanecarrier for efficient anticancer therapy［J］.J Control Release,2019,294:154-164.
[42]XU W,QIAN J,HOU G,et al.A dual-targeted hyaluronic acid-gold nanored platform with tripie-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer［J］.Acta Biomater,2019,83:400-413.
[43]KRUGER S,ILMER M,KOBOLD S,et al.Advances in cancer immunotherapy 2019-latest trends［J］.J Exp Clin Cancer Res,2019,38(1):268.
[44]WANG Y,WANG M,WU HX,et al.Advancing to the era of cancer immunotherapy［J］.Cancer Commun (Lond),2021,41(9):803-829.
[45]SCHLAKE T,THESS A,THRAN M,et al.mRNA as novel technology for passive immunotherapy［J］.Cell Mol Life Sci,2019,76(2):301-328.
[46]MA S,LI XC,WANG XY,et al.Current progress in CAR-T cell therapy for solid tumors［J］.Int J Biol Sci,2019,15(12):2548-2560.
[47]CHEN LP,HAN X.Anti-PD-1/PD-L1 therapy of human cancer:past,present,and future［J］.J Clin Invest,2015,125(9):3384-3391.
[48]SAXENA M,VAN DER BURG SH,MELIEF CJM,et al.Therapeutic cancer vaccines［J］.Nat Rev Cancer,2021,21(6):360-378.
[49]MAO Q,MIN J,ZENG R,et al.Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy［J］.Theranostics,2022,12(14):6088-6105.
[50]CAO M,YAN H,HAN X,et al.Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth［J］.J Immunother Cancer,2019,7(1):326.
[51]LI K,LIN C,HE Y,et al.Engineering of cascade-responsive nanoplatform to inhibit lactate efflux for enhanced tumor chemo-immunotherapy［J］.ACS Nano,2020,14(10):14164-14180.
[52]SONG Q,YIN Y,SHANG L,et al.Tumor microenvironment responsive nanogel for the combinatorial antitumor effect of chemotherapy and immunotherapy［J］.Nano Lett,2017,17:6366-6375.
[53]SU Z,XIAO Z,WANG Y,et al.Codelivery of anti-PD-1 antibody and paclitaxel with matrix metalloproteinase and pH dual-sensitive micelles for enhanced tumor chemoimmunotherapy［J］.Small,2020,16(7):e1906832.
[54]DAI L,LI X,YAO M,et al.Programmable prodrug micelle with size-shrinkage and charge-reversal for chemotherapy-improved IDO immunotherapy［J］.Biomaterials,2020,241:119901.
[55]TRIPLETT TA,GARRISON KC,MARSHALL N,et al.Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme［J］.Nat Biotechnol,2018,36(8):758-764.
[56]MUNN DH,BRONTE V.Immune suppressive mechanisms in the tumor microenvironment［J］.Curr Opin Immunol,2016,39:1-6.
[57]GU P,LIU Z,SUN Y,et al.Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses［J］.Int J Pharm,2019,554:72-80.
[58]GU P,WUSIMAN A,WANG S,et al.Polyethylenimine coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant to enhance immune responses［J］.Carbohydr Polym,2019,223:115128.
[59]LUO L,ZHENG S,HUANG Y,et al.Preparation and characterization of Chinese yam polysaccharide PLGA nanoparticles and their immunological activity［J］.Int J Pharm,2016,511(1):140-150.
[60]XU S,WUSIMAN A,LIU Z,et al.pH-responsive Astragalus polysaccharides-loaded poly(lactic-co-glycolic acid) nanoparticles and their in vitro immunogenicity［J］.Int J Biol Macromol,2019,125:865-875.
[61]ZHOU R,TENG L,ZHU Y,et al.Preparation of Amomum longiligulare polysaccharides 1-PLGA nanoparticle and its immune enhancement ability on RAW264.7 cells［J］.Int Immunopharmacol,2021,99:108053.
[62]LI N,HU YL,HE CX,et al.Preparation,characterisation and anti-tumour activity of Ganoderma Lucidum polysaccharide nanoparticles［J］.J Pharm Pharmacol,2010,62(1)：139.
[63]宋志磊,潘玉涛,黄新河,等.可作为疫苗佐剂的云芝多糖磷酸钙纳米粒的制备与表征［J］.天然产物研究与开发,2016,28(9):1357.
SONG ZL,PAN YT,HUANG XH,et al.Preparation and characterization of polysaccharide krestin calcium phosphate(PSK-CAP)nanoparticle as a vaccine adjuvant［J］.Nat Prod Res Dev,2016,28(9):1357.
[64]FAN YP,HU YL,WANG DY,et al.Effects of Astragalus polysaccharide liposome on lymphocyte proliferation in vitro and adjuvanticity in vivo［J］.Carbohydr Polym,2011,88(1):68-74.
[65]FAN Y,SONG X,GAO Y,et al.Preparation and optimization of ophiopogon polysaccharide liposome and its activity on Kupffer cells［J］.Int J Pharmaceut,2014,477(1-2):421-430.
[66]LUO L,ZHENG S,HUANG Y,et al.Preparation and characterization of Chinese yam polysaccharide PLGA nanoparticles and their immunological activity［J］.Int J Phann,2016,511(1):140.
[67]GU P,XU S,ZHOU S,et al .Optimization of Angelica sinensis polysaccharide-loaded poly(lactic-co-glycolicacid)nanoparticles by RSM and its immunological activity in vitro［J］.Int J Biol Macromol,2018,107(PtA):222-229.
[68]MASUMI S,GEN T,TOKIO T,et al.Characterization of novel paclitaxel nanoparticles prepared by laser irradiation［J］.Chem Pharm Bull (Tokyo),2022,70(4):269-276.
[69]CHEN H,WEN J.Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway［J］.Eur J Pharmacol,2022,921:174860.
[70]ALAVI M,NOKHODCHI A.Micro- and nanoformulations of paclitaxel based on micelles,liposomes,cubosomes,and lipid nanoparticles:Recent advances and challenges［J］.Drug Discov Today,2022,27(2):576-584.
[71]SCHMIDT KT,KARZAI F,BILUSIC M,et al.A single-arm phase II study combining NLG207,a nanoparticle camptothecin,with enzalutamide in advanced metastatic castration-resistant prostate cancer post-enzalutamide［J］.Oncologist,2022,27(9):718-e694.